TABLE 1 ] .
Baseline Characteristics for 122 Subjects Undergoing Lung Transplant for HP or IPF
| Baseline Characteristic | HP (n = 31) | IPF (n = 91) | P Value |
| Age, y | 56.9 ± 9.4 | 59.7 ± 7.7 | .19 |
| Male sex | 16 (51.6) | 66 (72.5) | .032a |
| Race | .50 | ||
| White, non-Hispanic | 24 (77.4) | 70 (76.9) | |
| Hispanic | 5 (16.1) | 9 (9.9) | |
| Other | 2 (6.5) | 12 (2.2) | |
| Exposure | … | ||
| Avian | 8 (25.8) | n/a | |
| Microbial | 4 (12.9) | n/a | |
| Unknown | 19 (61.3) | n/a | |
| Ever smoker | 16 (51.6) | 52 (57.1) | .59 |
| BMI | 25.6 ± 4.1 | 26.1 ± 3.9 | .50 |
| Creatinine level | 0.83 ± 0.23 | 0.90 ± 0.26 | .20 |
| FEV1 % predicted | 42.1 ± 14.1 | 54.4 ± 16.8 | < .001a |
| FVC % predicted | 37.6 ± 12.5 | 49.9 ± 16.1 | < .001a |
| FEV1/FVC | 0.85 | 0.84 | .44 |
| Mean PAP, mm Hg | 23.0 ± 8.9 | 22.8 ± 9.6 | .92 |
| Lung allocation score | 56.3 ± 14.9 | 56.5 ± 19.4 | .42 |
| Chronic oral steroids before transplant | 24 (77.4) | 43 (49.4) | < .05a |
| Donor age, y | 33.4 ± 14.6 | 32.7 ± 13.4 | .81 |
| Bilateral lung transplant | 27 (87.1) | 68 (74.7) | .15 |
| Ischemic time, h | 5.47 ± 0.96 | 5.50 ± 1.41 | .91 |
Data presented as mean ± SD or No. (%). HP = hypersensitivity pneumonitis; IPF = idiopathic pulmonary fibrosis; PAP = pulmonary artery pressure.
Statistically significant at P ≤ .05.